文献速递艾滋病与性传播感染

全球人类免疫缺陷病毒感染者的初级心血管疾病预防队列中接受抗逆转录病毒治疗者系统性免疫激活指标的相关因素

Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该研究基于REPRIEVE试验基线数据,纳入4907例接受抗逆转录病毒治疗的人类免疫缺陷病毒感染者,分析可溶性CD14(sCD14)和氧化低密度脂蛋白(oxLDL)的相关因素。结果显示两者相关因素不同:女性、白人种族与较高sCD14相关,较高体重指数与较低sCD14相关;男性、高收入地区居住、白人种族和较高体重指数与较高oxLDL相关。在1396例女性亚组中,生殖年龄增加与较高sCD14相关。

要点

  • 在4907例接受抗逆转录病毒治疗的人类免疫缺陷病毒感染者中,sCD14和oxLDL的相关因素不同。
  • 女性、白人种族与较高sCD14相关,较高体重指数和当前使用核苷逆转录酶抑制剂+整合酶链转移抑制剂方案与较低sCD14相关。
  • 男性、高收入地区居住、白人种族和较高体重指数与较高oxLDL相关;在1396例女性中生殖年龄增加与较高sCD14相关。

核心结论

  • sCD14和oxLDL这两种免疫介导心血管疾病风险的关键指标,其相关因素不同;未来研究将阐明他汀类药物和行为改变如何影响sCD14和oxLDL,以及这些标志物的抑制在多大程度上介导心血管保护效应。

研究设计与样本

  • 利用REPRIEVE试验基线数据,评估与sCD14和oxLDL相关的因素。
  • 主要分析队列包括来自5个全球疾病负担区域的4907例参与者,女性占38%,黑人占48%,中位年龄50岁。
  • 亚组分析纳入1396例女性人类免疫缺陷病毒感染者。

主要发现

  • 在sCD14完全校正模型中,女性性别和白人种族(高收入地区人群中)与较高sCD14水平相关,较高体重指数和当前使用核苷逆转录酶抑制剂+整合酶链转移抑制剂方案与较低sCD14水平相关。
  • 在oxLDL完全校正模型中,男性性别、高收入地区居住、白人种族(高收入地区人群中)和较高体重指数与较高oxLDL水平相关。
  • 在1396例女性亚组中,生殖年龄增加与较高sCD14水平相关,但与较高oxLDL水平无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Among antiretroviral therapy (ART)-treated people with human immunodeficiency virus (PWH), persistent systemic immune activation contributes to atherogenesis atherosclerotic, cardiovascular disease (CVD) events, and mortality. Factors associated with key immune activation indices have not previously been characterized among a global primary CVD prevention cohort of PWH. METHODS: Leveraging baseline Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) data, we evaluated factors associated with soluble CD14 (sCD14) and oxidized low-density lipoprotein (oxLDL). RESULTS: The primary analysis cohort included 4907 participants from 5 global-burden-of-disease regions (38% female, 48% Black, median age 50 years). In fully adjusted models for sCD14, female sex and White race (among those in high-income regions) were associated with higher sCD14 levels, while higher body mass index (BMI) and current use of nucleoside reverse transcriptase inhibitor + integrase strand transfer inhibitor ART were associated with lower sCD14 levels. In fully adjusted models for oxLDL, male sex, residence in high-income regions, White race (among those in high-income regions), and higher BMI were associated with higher oxLDL levels. In a subanalysis cohort of 1396 women with HIV, increased reproductive age was associated with higher sCD14 levels but not with higher oxLDL levels. CONCLUSIONS: Factors associated with sCD14 and oxLDL, 2 key indices of immune-mediated CVD risk, differ. Future studies will elucidate ways in which medications (eg, statins) and behavioral modifications influence sCD14 and oxLDL and the extent to which dampening of these markers mediates CVD-protective effects. CLINICAL TRIALS REGISTRATION: NCT0234429.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Looby SE, Kantor A, Burdo TH, et al. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2022. PMID: 35235653. doi:10.1093/cid/ciac166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。